SODIUM CHLORIDE- sodium chloride injection 
Baxter Healthcare Corporation

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

0.9% Sodium Chloride Injection, USP

HEALTH CARE PROVIDER LETTER

DHCP Letter 1
DHCP Letter 2
DHCP Letter 3
DHCP Letter 4
DHCP Letter 5
DHCP Letter 6
DHCP Letter 7
DHCP Letter 8
DHCP Letter 9
DHCP Letter 10
DHCP Letter 11
DHCP Letter 12
DHCP Letter 13
DHCP Letter 14
DHCP Letter 15
DHCP Letter 16
DHCP Letter 17

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Sodium Chloride JB1301 Representative Container Label

Container Label

JB1301
50 mL

0.9%Sodium Chloride Injection USP

DIN 00060208
APPROX mmol/L Na - 154 Cl - 154
mOsmol/L 308 pH 5.5
SINGLE DOSE/DOSAGE UNIQUE

Barcode (01)00809080001040

PER/PAR mL SODIUM CHLORIDE USP / CHLORURE DE SODIUM USP - 9 mg pH MAY BE ADJUSTED WITH SODIUM HYDROXIDE / IV FLUID AND ELECTROLYTE REPLENISHER USE AS PRESCRIBED / PRESCRIBING INFORMATION AVAILABLE UPON REQUEST / SQUEEZE AND INSPECT BAG / DISCARD IF LEAKING / MUST NOT BE USED IN SERIES CONNECTIONS / STORE AT 15°C TO 25°C

pH PEUT ETRE AJUSTE AVEC DE L’HYDROXYDE DE SODIUM SOLUTION / IV AVEC ELECTROLYTES ADMINISTRER TEL QUE PRESCRIT PAR LE MEDECIN / INFORMATION POSOLOGIQUE DISPONIBLE SUR DEMANDE / PRESSER ET INSPECTER LE SAC / JETER EN CAS DE FUITES / NE DOIT PAS ETRE MONTE EN SERIE / GARDER ENTRE 15 °C ET 25 °C

NONPYROGENIC / STERILE / APYROGENE
VIAFLEX® PVC CONTAINER / CONTENANT DE PVC

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No LATEX Logo
88-70-20-410

Sodium Chloride JB1302 Representative Container Label

Container Label

JB1302
100 mL

0.9% Sodium Chloride Injection USP

DIN 00060208
APPROX mmol/L Na - 154 Cl -154
mOsmol/L 308 pH 5.5
SINGLE DOSE / DOSAGE UNIQUE

Barcode (01)00809080001057

PER/PAR mL SODIUM CHLORIDE USP/
CHLORURE DE SODIUM USP - 9 mg
pH MAY BE ADJUSTED WITH SODIUM
HYDROXIDE / IV FLUID AND ELECTRO-
LYTE REPLENISHER / USE AS PRE-
SCRIBED / PRESCRIBING INFORMA-
TION AVAILABLE UPON REQUEST /
SQUEEZE AND INSPECT BAG / DISCARD IF LEAKING /
MUST NOT BE USED IN SERIES CONNECTIONS / STORE
AT 15°C - 25°C

pH PEUT ETRE AJUSTE AVEC DE L’HYDROXYDE DE SODIUM / SO-
LUTION IV AVEC ELECTROLYTES /
ADMINISTRER TEL QUE PRESCRIT PAR LE MEDECIN / IN-
FORMATION POSOLOGIQUE DISPONIBLE SUR DEMANDE
PRESSER ET INSPECTER LE SAC / JETER EN CAS DE
FUITES / NE DOIT PAS ETRE MONTE EN SERIE / GARDER
ENTRE 15 °C ET 25 °C

NONPYROGENIC / STERILE / APYROGENE
VIAFLEX® PVC CONTAINER / CONTENANT DE PVC

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No LATEX Logo
88-70-20-411

Sodium Chloride JB1322 Representative Container Label

Container Label

JB1322
250 mL
DIN 00060208
0.9% Sodium Chloride Injection USP
Chlorure de Sodium à 0.9% USP, Injectable

NaCl 0.9%
Barcode (01)00809080000562

APPROX mmol/L Na-154 Cl - 154
mOsmol/L 308

APPROX pH 5.5

INTRAVENOUS FLUID AND ELEC-
TROLYTE REPLENISHMENT / RET-
ABLISSEMENT HYDRO-ELECTRO-
LYTIQUE PAR INJECTION INTRA-
VEINEUSE

PER 100 mL SODIUM CHLORIDE USP - 900 mg / WATER
FOR INJECTION USP - qs / WATER FOR INJECTION USP
qs / pH MAY BE ADJUSTED WITH SODIUM HYDROXIDE

PAR 100 mL CHORURE DE SODIUM USP - 900 mg / EAU
POUR INJECTION USP - qs / pH PEUT ETRE AJUSTE
AVEC DE L’HYDROXYDE DE SODIUM

CAUTIONS SINGLE USE / DISCARD UNUSED PORTION /
SQUEEZE AND INSPECT BAG / PRESCRIBING INFORMA-
TION AVAILABLE UPON REQUEST / MUST NOT BE USED
IN SERIES CONNECTIONS / STORE AT 15°C TO 25°C
ATTENTIONS USAGE UNIQUE / JETER PORTION INUTILI-
SEE / PRESSER ET INSPECTER LE SAC / INFORMATION
POSOLOGIQUE DISPONIBLE SUR DEMANDE / NE DOIT
PAS ETRE MONTE EN SERIE / GARDER ENTRE 15°C ET
25°C

NONPYROGENIC / STERILE APYROGENE
VIAFLEX® PVC CONTAINER/CONTENANT DE PVC

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No LATEX Logo
88-70-20-415

50

100

150

200

Sodium Chloride JB1323 Representative Container Label

Container Label

JB1323
500 mL
DIN 00060208

0.9% Sodium Chloride
Injection USP
Chlorure de Sodium à
0.9% USP, Injectable

NaCl 0.9%
APPROX mmol/L Na - 154 Cl - 154 mOsmol/L - 308 pH 5.5

RETABLISSEMENT HYDRO-ELECTROLYTIQUE / PAR INJECTION
INTRAVEINEUSE
PER 100 mL SODIUM CHLORIDE USP - 900 mg / WATER FOR
INJECTION USP – qs
PAR 100 mL CHLORURE DE SODIUM USP - 900 mg / EAU POUR
INJECTION USP - qs

CAUTIONS SINGLE USE / DISCARD UNUSED PORTION / SQUEEZE
AND INSPECT BAG / SEE DIRECTIONS FOR USE / MUST NOT BE
USED IN SERIES CONNECTIONS / STORE AT 15° C TO 25° C

ATTENTIONS USAGE UNIQUE / JETER PORTION INUTILISEE /
PRESSER ET INSPECTER LE SAC / VOIR MODE D’EMPLOI / NE DOIT
PAS ETRE MONTE EN SERIE / GARDER ENTRE 15° C ET 25° C

NONPYROGENIC / STERILE / APYROGENE
VIAFLEX PVC CONTAINER/ CONTENANT DE PVC

BAXTER AND VIAFLEX ARE TRADEMARKS OF BAXTER INTERNATIONAL INC
BAXTER ET VIAFLEX SONT DES MARQUES DE COMMERCE DE BAXTER
INTERNATIONAL INC

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No LATEX Logo
07-25-77-317

1

2

3

4

Sodium Chloride JB1324 Representative Container Label

Container Label

JB1324
1000 mL
DIN 00060208

0.9% Sodium Chlo-
ride Injection USP

Chlorure de Sodium à
0.9% USP, Injectable

NaCl 0.9%

APPROX mmol/L Na - 154 Cl - 154
mOsmol/L - 308 pH 5.5

INTRAVENOUS FLUID AND ELECTROLYTE
REPLENISHMENT / RETABLISSEMENT HYDRO-
ELECTROLYTIQUE PAR INJECTION INTRAVEINEUSE

PER 100 mL SODIUM CHLORIDE USP - 900 mg / WATER
FOR INJECTION USP – qs

PAR 100 mL CHLORURE DE SODIUM USP - 900 mg / EAU
POUR INJECTION USP – qs

CAUTIONS SINGLE USE / DISCARD UNUSED PORTION
SQUEEZE AND INSPECT BAG / PRESCRIBING INFORMA-
TION AVAILABLE UPON REQUEST / MUST NOT BE USED
IN SERIES CONNECTIONS / STORE AT 15° C TO 25° C

ATTENTIONS USAGE UNIQUE / JETER PORTION
INUTILISEE / PRESSER ET INSPECTER LE SAC / INFOR-
MATION POSOLOGIQUE DISPONIBLE SUR DEMANDE /
NE DOIT PAS ETRE MONTE EN SERIE / GARDER ENTRE
15° C ET 25° C
NONPYROGENIC / STERILE / APYROGENE

VIAFLEX PVC CONTAINER / CONTENANT DE PVC
BAXTER AND VIAFLEX ARE TRADEMARKS OF BAXTER INTERNATIONAL INC
BAXTER ET VIAFLEX SONT DES MARQUES DE COMMERCE DE
BAXTER INTERNATIONAL INC

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No LATEX Logo
88-70-20-490

1

2

3

4

5

6

7

8

9

SODIUM CHLORIDE 
sodium chloride injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9579
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE9 mg  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0338-9579-9696 in 1 CARTON10/13/201703/31/2019
150 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage10/13/201703/31/2019
SODIUM CHLORIDE 
sodium chloride injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9583
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE9 mg  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0338-9583-9696 in 1 CARTON10/13/201703/31/2019
1100 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage10/13/201703/31/2019
SODIUM CHLORIDE 
sodium chloride injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9604
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE900 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0338-9604-3030 in 1 CARTON10/13/201703/31/2019
1250 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage10/13/201703/31/2019
SODIUM CHLORIDE 
sodium chloride injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9608
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE900 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0338-9608-2424 in 1 CARTON10/13/201708/31/2019
1500 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage10/13/201708/31/2019
SODIUM CHLORIDE 
sodium chloride injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9612
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE900 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0338-9612-1212 in 1 CARTON10/13/201710/31/2019
11000 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug for use in drug shortage10/13/201710/31/2019
Labeler - Baxter Healthcare Corporation (005083209)

Revised: 4/2024
Document Id: 107b17ac-e5f1-44d2-9e3a-9d247ff869c3
Set id: 6d94bf83-b952-4553-a351-f5c23cd647e5
Version: 5
Effective Time: 20240402
 
Baxter Healthcare Corporation